Idorsia Ltd. (IDRSF)
7.25
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Idorsia Total Assets (Quarterly) : 575.13M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 575.13M |
| March 31, 2026 | 597.92M |
| December 31, 2025 | 588.04M |
| September 30, 2025 | 571.32M |
| June 30, 2025 | 625.64M |
| March 31, 2025 | 515.59M |
| December 31, 2024 | 558.23M |
| September 30, 2024 | 512.84M |
| June 30, 2024 | 745.67M |
| March 31, 2024 | 866.65M |
| December 31, 2023 | 594.07M |
| September 30, 2023 | 713.95M |
| June 30, 2023 | 589.91M |
| March 31, 2023 | 764.45M |
| December 31, 2022 | 977.28M |
| September 30, 2022 | 1.041B |
| June 30, 2022 | 1.107B |
| March 31, 2022 | 1.366B |
| December 31, 2021 | 1.628B |
| Date | Value |
|---|---|
| September 30, 2021 | 1.799B |
| June 30, 2021 | 1.284B |
| March 31, 2021 | 1.379B |
| December 31, 2020 | 1.624B |
| September 30, 2020 | 1.142B |
| June 30, 2020 | 1.223B |
| March 31, 2020 | 911.32M |
| December 31, 2019 | 1.037B |
| September 30, 2019 | 1.130B |
| June 30, 2019 | 1.293B |
| March 31, 2019 | 1.366B |
| December 31, 2018 | 1.427B |
| September 30, 2018 | 1.564B |
| June 30, 2018 | 1.136B |
| March 31, 2018 | 1.253B |
| December 31, 2017 | 1.326B |
| September 30, 2017 | 1.173B |
| June 30, 2017 | 1.245B |
| March 31, 2017 | 812.21M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 9.176B |
| AC Immune SA | 186.45M |
| CRISPR Therapeutics AG | 2.651B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.055B |
| Shareholders Equity (Quarterly) | -1.480B |
| Debt to Equity Ratio | -1.124 |
| Current Ratio | 0.5819 |
| Net Debt Paydown Yield | -2.55% |